methyl 4-(hydroxymethyl)bicyclo[2.2.1]heptane-1-carboxylate, 95.0%, 100mg

2-Phenyloxazole, 95.0%, 5g

2-hydrazinyl-4-(1H-imidazol-1-yl)-6-methylpyrimidine, 95.0%, 250mg

(6-Bromo-2-fluoro-3-iodophenyl)boronic acid, 95.0%, 1g

N-(Piperidin-4-yl)pyridine-2-sulfonamidedihydrochloride, 95.0%, 1g

IPTG, >98%, 100g

3-Bromo-2-fluoro-6-(trifluormethyl)benzaldehyde, 95.0%, 5g

4-Hydroxy-5-((4-methoxybenzyl)oxy)-1,4-dihydropyridine-2-carboxylic acid, 95.0%, 250mg

4-Nitro-2-thiophenecarboxylic acid, 95.0%, 100mg

Methanesulfonic acid, min. 99.5%, for synthesis, 100 ml, glass packaging

m-Tolidine>98.0%(GC)(T)25g

4-(hexyloxy)phenol, 95.0%, 5g

6-(Trifluoromethoxy)-1H-indole-2-carboxylic acid, 95.0%, 250mg